The next Alzheimer’s treatment could come from an unexpected place. In new research released this week, scientists have found ...
Bristol Myers Squibb plans to release initial late-stage trial data on Cobenfy in Alzheimer’s-related psychosis during the ...
Kyung Bo Kim discovered compounds that improved cognitive function regardless of amyloid plaque buildup — an encouraging sign ...
Alzheimer’s is the most common form of dementia — it causes memory loss, confusion, thinking problems and behavioral changes.
The gas xenon, like the other noble, or inert, gases, is known for doing very little. The class of elements, because of its ...
Researchers have found that a widely used anesthesia gas can help lower the progression of Alzheimer's disease.
A breakthrough study highlights Xenon gas as a potential game-changer in treating Alzheimer’s disease, demonstrating its ...
Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the ...
The study included nearly 2 million patients, making it the largest ever conducted on this group of glucagon-like peptide-1 ...
Researchers report hopeful progress in efforts to find treatments for Alzheimer’s disease. They report a recent clinical ...
Advances in scientific research and diagnostic tools are transforming how we think about and treat Alzheimer’s disease.
Innovative Research Combines Ayurvedic Medicine and Chemically Designed Peptides to Combat Amyloid Aggregation in ...